COPD 360 Solutions is intended to be a tool adjunctive to the clinical judgment of a licensed clinician, adequately trained in the care of patients. In no way should the guidance indicated or information displayed in any part of this software be considered as exhaustive in deciding what is appropriate when treating any patient; any decision made using this tool should be set against sound clinical judgment based upon up-to-date research, the knowledge of which is the sole responsibility of the clinician directly caring for the patient.
The “MED Inc. - COPD Risk Index” has not been verified by validation study but aggregates questions from and is inspired by several validated COPD questionnaires and tests including: "Modified Medical Research Council Dyspnea Scale (mMRC)", "BODE Index for COPD Survival", "BAP-65 Score for Acute Exacerbation of COPD", “Clinical COPD Questionnaire (CCQ)” and has been adapted for outpatient use to decrease need for specialized testing, like ABG. In no way should this be used to determine appropriate treatments for any patient, and is meant to aid a qualified clinician in better understanding the current status of a patient under their care.